To become a therapeutic expert in rare, genetic conditions and facilitate dissemination of clinical and scientific information in a compliant and fair-balanced manner to internal and external stakeholders. Fellows will collaborate cross-functionally to lead high-impact projects to drive the overall medical strategy. This fellowship will prepare the candidates for a field-based Medical Science Liaison (MSL) position.
Prepare for the role of a field-based Medical Science Liaison within US Rare Disease Medical Affairs by participating in new MSL training and completing MSL certification.
Collaborate with Medical Directors and Medical Science Liaisons, and lead Medical Affairs projects, including creation of internal and external deliverables, congress planning, and managing Medical Affairs Journal Club.
Attend medical and scientific meetings and congresses to ensure an in-depth understanding of cutting-edge information that will help shape the Medical Affairs strategy.
Gain MSL experience by working in the field with an MSL mentor, thereby gaining skills in scientific engagement and relationship building.
Collaborate with Medical Science Liaison Disease Expert Teams and external agencies on the development of core clinical and training materials.
Lead disease state and treatment training sessions for internal commercial colleagues.
Establish collaborative relationships with internal colleagues in various departments within Sanofi Genzyme, as well as external stakeholders.
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal due by December 2, 2019:
Letter of intent
Unofficial college transcript
Contact information of three references for their recommendations.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three letters of recommendation must be submitted by the three provided contacts no later than December 16th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance
About MCPHS University/Sanofi Genzyme
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.